Amanote Research
Register
Sign In
Metformin Treatment of Antipsychotic-Induced Dyslipidemia: An Analysis of Two Randomized, Placebo-Controlled Trials
Molecular Psychiatry
- United Kingdom
doi 10.1038/mp.2015.221
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Molecular Neuroscience
Mental Health
Molecular Biology
Cellular
Date
January 26, 2016
Authors
R-R Wu
F-Y Zhang
K-M Gao
J-J Ou
P Shao
H Jin
W-B Guo
P K Chan
J-P Zhao
Publisher
Springer Science and Business Media LLC
Related search
Mirtazapine for Antipsychotic-Induced Acute Akathisia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Therapeutic Advances in Psychopharmacology
Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
Gut and Liver
Hepatology
Gastroenterology
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Placebo Response in Antipsychotic Clinical Trials
JAMA Psychiatry
Medicine
Psychiatry
Mental Health
Dropout Rates in Placebo-Controlled and Active-Control Clinical Trials of Antipsychotic Drugs
Archives of General Psychiatry
Optimizing the Design of Invasive Placebo Interventions in Randomized Controlled Trials
British Journal of Surgery
Surgery
Lifestyle Intervention and Metformin for Treatment of Antipsychotic-Induced Weight Gain
JAMA - Journal of the American Medical Association
Medicine
Adjunctive Peony-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinaemia: A Meta-Analysis of Randomised Controlled Trials
General Psychiatry
Psychiatry
Mental Health
Neurology
Effects of Coenzyme Q10 on Statin‐Induced Myopathy: An Updated Meta‐Analysis of Randomized Controlled Trials
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
